Abstract
The histological breakdown of a consecutive series of 264 surgically resected malignant lesions of the breast was studied. Oestrogen and epidermal growth factor receptor status was quantified and presented along with size and lymph node status of the non-ductal lesions. Those non-ductal tumours containing EGF receptors have all recurred within two years of resection. Twenty-one percent of the lobular carcinomas contained EGF receptors compared to 34% of ductal carcinomas. EGF receptor status appeared to be associated with an increased risk of early recurrence and death whatever the histological sub-type of the breast cancer.
Full text
PDF![458](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/2246782/fb5a9c4ff9a6/brjcancer00132-0056.png)
![459](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/2246782/25f0b12cc5cb/brjcancer00132-0057.png)
![460](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac98/2246782/61a870c5c38e/brjcancer00132-0058.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benson E. A., Holdaway I. M. Insulin receptors in human cancer. Br J Cancer. 1981 Dec;44(6):917–920. doi: 10.1038/bjc.1981.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dickson R. B., McManaway M. E., Lippman M. E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science. 1986 Jun 20;232(4757):1540–1543. doi: 10.1126/science.3715461. [DOI] [PubMed] [Google Scholar]
- Dixon J. M., Page D. L., Anderson T. J., Lee D., Elton R. A., Stewart H. J., Forrest A. P. Long-term survivors after breast cancer. Br J Surg. 1985 Jun;72(6):445–448. doi: 10.1002/bjs.1800720614. [DOI] [PubMed] [Google Scholar]
- Downward J., Yarden Y., Mayes E., Scrace G., Totty N., Stockwell P., Ullrich A., Schlessinger J., Waterfield M. D. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 1984 Feb 9;307(5951):521–527. doi: 10.1038/307521a0. [DOI] [PubMed] [Google Scholar]
- Filmus J., Trent J. M., Pollak M. N., Buick R. N. Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. Mol Cell Biol. 1987 Jan;7(1):251–257. doi: 10.1128/mcb.7.1.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fitzpatrick S. L., Brightwell J., Wittliff J. L., Barrows G. H., Schultz G. S. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res. 1984 Aug;44(8):3448–3453. [PubMed] [Google Scholar]
- Fitzpatrick S. L., LaChance M. P., Schultz G. S. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res. 1984 Aug;44(8):3442–3447. [PubMed] [Google Scholar]
- Hofmann G. E., Rao C. V., Barrows G. H., Schultz G. S., Sanfilippo J. S. Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J Clin Endocrinol Metab. 1984 May;58(5):880–884. doi: 10.1210/jcem-58-5-880. [DOI] [PubMed] [Google Scholar]
- Horwitz K. B., McGuire W. L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem. 1978 Apr 10;253(7):2223–2228. [PubMed] [Google Scholar]
- Howell A., Barnes D. M., Harland R. N., Redford J., Bramwell V. H., Wilkinson M. J., Swindell R., Crowther D., Sellwood R. A. Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet. 1984 Mar 17;1(8377):588–591. doi: 10.1016/s0140-6736(84)90995-4. [DOI] [PubMed] [Google Scholar]
- Murphy L. J., Vrhovsek E., Sutherland R. L., Lazarus L. Growth hormone binding to cultured human breast cancer cells. J Clin Endocrinol Metab. 1984 Jan;58(1):149–156. doi: 10.1210/jcem-58-1-149. [DOI] [PubMed] [Google Scholar]
- Neal D. E., Marsh C., Bennett M. K., Abel P. D., Hall R. R., Sainsbury J. R., Harris A. L. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet. 1985 Feb 16;1(8425):366–368. doi: 10.1016/s0140-6736(85)91386-8. [DOI] [PubMed] [Google Scholar]
- Nicholson S., Sainsbury J. R., Needham G. K., Chambers P., Farndon J. R., Harris A. L. Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer. 1988 Jul 15;42(1):36–41. doi: 10.1002/ijc.2910420108. [DOI] [PubMed] [Google Scholar]
- Pérez R., Pascual M., Macías A., Lage A. Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treat. 1984;4(3):189–193. doi: 10.1007/BF01806484. [DOI] [PubMed] [Google Scholar]
- Rozengurt E., Sinnett-Smith J., Taylor-Papadimitriou J. Production of PDGF-like growth factor by breast cancer cell lines. Int J Cancer. 1985 Aug 15;36(2):247–252. doi: 10.1002/ijc.2910360218. [DOI] [PubMed] [Google Scholar]
- Sainsbury J. R., Farndon J. R., Harris A. L., Sherbet G. V. Epidermal growth factor receptors on human breast cancers. Br J Surg. 1985 Mar;72(3):186–188. doi: 10.1002/bjs.1800720309. [DOI] [PubMed] [Google Scholar]
- Sainsbury J. R., Farndon J. R., Needham G. K., Malcolm A. J., Harris A. L. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987 Jun 20;1(8547):1398–1402. doi: 10.1016/s0140-6736(87)90593-9. [DOI] [PubMed] [Google Scholar]
- Sainsbury J. R., Farndon J. R., Sherbet G. V., Harris A. L. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet. 1985 Feb 16;1(8425):364–366. doi: 10.1016/s0140-6736(85)91385-6. [DOI] [PubMed] [Google Scholar]
- Sainsbury J. R., Malcolm A. J., Appleton D. R., Farndon J. R., Harris A. L. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol. 1985 Nov;38(11):1225–1228. doi: 10.1136/jcp.38.11.1225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Salomon D. S., Zwiebel J. A., Bano M., Losonczy I., Fehnel P., Kidwell W. R. Presence of transforming growth factors in human breast cancer cells. Cancer Res. 1984 Sep;44(9):4069–4077. [PubMed] [Google Scholar]
- Shiu R. P. Prolactin receptors in human breast cancer cells in long-term tissue culture. Cancer Res. 1979 Nov;39(11):4381–4386. [PubMed] [Google Scholar]
- Skoog L., Macias A., Azavedo E., Lombardero J., Klintenberg C. Receptors for EGF and oestradiol and thymidinekinase activity in different histological subgroups of human mammary carcinomas. Br J Cancer. 1986 Aug;54(2):271–276. doi: 10.1038/bjc.1986.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987 Jan 9;235(4785):177–182. doi: 10.1126/science.3798106. [DOI] [PubMed] [Google Scholar]
- Stewart J. F., King R. J., Sexton S. A., Millis R. R., Rubens R. D., Hayward J. L. Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer. 1981 Apr;17(4):449–453. doi: 10.1016/0014-2964(81)90254-1. [DOI] [PubMed] [Google Scholar]
- Tahara E., Sumiyoshi H., Hata J., Yasui W., Taniyama K., Hayashi T., Nagae S., Sakamoto S. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy. Jpn J Cancer Res. 1986 Feb;77(2):145–152. [PubMed] [Google Scholar]